Neil Canavan MSc

Neil joined the Trout Group in 2014. Prior to joining, Neil was a freelance journalist specializing in science and medicine, writing for such news outlets as WebMD, Medscape, The Scientist, and Drug Discovery and Development magazine. In addition to his scientific advisory role at Trout, Neil currently serves as a contributing editor to The Oncology Business Review.